On Thursday (January 18) a cannabis operator trading in Canada but focused in the US market strengthened its efforts in Florida, where investors could see a race for the market share heating up.
iAnthus Capital Holdings (CSE:IAN; OTCQB:ITHUF) announced it acquired the assets of GrowHealthy Holdings a local Florida company formed in 2014, which includes its affiliate McCrory’s Sunny Hill Nursery that holds one out of the 13 current Florida Medical Marijuana Treatment Centers.
“The state’s population includes a large percentage of older adults who can derive significant benefits from medical cannabis,” Randy Maslow, president of iAnthus said in the announcement.
The company explained to shareholders it paid $17.5 million in cash and “$30,500,000 was satisfied in iAnthus common shares at a price per share of $2.52.”
The cannabis producer won’t be getting a finished facility. Rather, the company will complete it with its own resources and is promising a 200,000 square feet cultivation space capable of producing 18,000 kilograms of cannabis flower per year once completed. No timetable was given for the completion of this facility.
“The GrowHealthy cultivation and operations team has already established itself as a leader in Florida’s medical cannabis market, and we look forward to contributing iAnthus’ capital and operational resources to fully build out GrowHealthy’s infrastructure,” Maslow said.

Competition brews in Florida for medical cannabis market control

One of the current leaders in the state of Florida, as far as public players focused on medical cannabis, is Liberty Health Sciences (CSE:LHS; OTCQX:LHSIF). This company launched last year with the backup from one of the major Licensed Producers (LPs) in Canada, Aphria (TSX:APH; OTC:APHQF).
Liberty Health recently opened its inaugural dispensary in the state, where a retirement community was specifically placed. Liberty Health expects to open another Florida location in the early part of 2018, increasing its sites to five.
Companies trading in Canadian exchanges but focusing on the American market or even holding direct interests there have faced scrutiny over the legality of this particular situation.
Most famously last year the TMX Group, which sees over the Toronto Stock Exchange (TSX) and the TSXV Ventures Exchange, issued a warning to publicly listed companies operating with aspirations in the US.


 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Investor Takeaway

While the year is still young, shares for iAnthus have steadily been increasing in value. value steadily this year. So far in 2018, the company’s share price has gone up 52 percent. However, by market close on Thursday the company’s share price dropped 3.55 percent.
For Liberty Health, its share price has been trending downwards. Year-to-date, its share price has declined 14.49 percent. The entire cannabis market suffered a big blow after US Attorney General Jeff Sessions rescinded the Cole Memo, a guidance for cannabis businesses in the country protecting them from federal persecution.
That said, shares of Liberty Health have increased in value 28.26 since launching on the Canadian Securities Exchange last year.
As the cannabis market in the US begins to develop it’s key to watch closely the development of areas of interest like Nevada and California, where public companies are facing one another and competing with local businesses. According to data from Arcview Market Research, as shared by iAnthus, the Florida medical cannabis market is expected to reach a billion dollars by 2020.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less